Vytrus Biotech S.A. Strategic Asset Allocation Index
Vytrus Biotech S.A. strategic asset allocation index. Vytrus Biotech S.A. (VYT) has a Strategic Asset Allocation Index of 21.6% as of December 2022. Strategic assets (PP&E of €1.03 Million plus long-term investments of €-) total €1.03 Million, measured against net assets of €4.75 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See VYT equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Vytrus Biotech S.A. (2020–2022)
Strategic asset allocation index of Vytrus Biotech S.A. from 2020 to 2022. This chart shows how Vytrus Biotech S.A.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 21.6%, representing strategic assets of €1.03 Million against net assets of €4.75 Million EUR. Check tangible net worth ratio of Vytrus Biotech S.A. to evaluate the tangible quality of the company's equity base.
Vytrus Biotech S.A. Strategic Asset Allocation Index by Year (2020–2022)
Vytrus Biotech S.A. strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Vytrus Biotech S.A. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Vytrus Biotech S.A. (VYT) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 21.6% | €1.03 Million | €1.03 Million | €- | €4.75 Million | ▲ +5.6 pp |
| 2021 | 16.0% | €678.42K | €678.42K | €- | €4.25 Million | ▲ +0.0 pp |
| 2020 | 15.9% | €574.73K | €574.73K | €- | €3.61 Million | — |